Zymeworks Inc. (ZYME)
NASDAQ: ZYME · Real-Time Price · USD
12.02
+0.71 (6.28%)
At close: May 12, 2025, 4:00 PM
12.02
0.00 (0.00%)
After-hours: May 12, 2025, 6:37 PM EDT
Zymeworks Market Cap
Zymeworks has a market cap or net worth of $837.60 million as of May 12, 2025. Its market cap has increased by 38.81% in one year.
Market Cap
837.60M
Enterprise Value
534.45M
1-Year Change
38.81%
Ranking
Category
Stock Price
$12.02
Market Cap Chart
Since April 28, 2017, Zymeworks's market cap has increased from $329.40M to $837.60M, an increase of 154.28%. That is a compound annual growth rate of 12.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 787.80M | -21.88% |
| Dec 31, 2024 | 1.01B | 38.65% |
| Dec 29, 2023 | 727.30M | 46.87% |
| Dec 30, 2022 | 495.20M | -35.10% |
| Dec 31, 2021 | 763.00M | -64.77% |
| Dec 31, 2020 | 2.17B | 20.97% |
| Dec 31, 2019 | 1.79B | 281.53% |
| Dec 31, 2018 | 469.30M | 143.92% |
| Dec 29, 2017 | 192.40M | -41.59% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |